GGrantIndex
Sort

48,018 grants matching immunotherapy

PERSONALIZED T CELL IMMUNOTHERAPY FOR RENAL CELL CARCINOMA

$634,326
University Of Washington · · FY2019 · Defense Health Agency

Targeting tumor metabolism and immune environment via beta-catenin: Towards precision medicine in HCC

$634,298
Satdarshan Singh Monga · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA

Regulatory T cells in cancer therapy

$634,296
Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2023 · CA

Targeting macrophage polarization to optimize muscle regrowth from disuse atrophy

$634,259
Micah J Drummond · University Of Utah · R56 · FY2020 · AG

Gamma delta T cell based melanoma therapies

$634,246
Xiaowei Xu · University Of Pennsylvania · R01 · FY2025 · CA

Optimizing TCR-CD3 signaling for immunotherapy of cancer

$634,208
Michelle Krogsgaard · New York University School Of Medicine · R01 · FY2025 · CA

Bioinstructive Scaffolds for Potent and Affordable CAR-T Cell Therapy Against Brain Tumors

$634,205
Yevgeny Brudno · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA

Lung Cancer Care Outcomes/Surveillance Consortium-Iowa

$634,196
University Of Iowa · U01 · FY2003 · CA

Strategies for Cancer Immunotherapy Development: Preclinical Studies

$634,145
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Strategies for Cancer Immunotherapy Clinical Trials

$634,145
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

The role of brain resident T cells in Alzheimer's disease

$634,144
Pamela Rosato · Dartmouth College · R01 · FY2025 · AG

Tumor-associated pDC (TApDC) in liver cancer with HIV infection

$634,061
Lishan Su · University Of Maryland Baltimore · R01 · FY2025 · CA

Molecular Pathobiology of Cryptococcus neoformans

$633,988
Peter Williamson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Lymphangiogenesis in Pulmonary Lymphangioleiomyomatosis (LAM)

$633,911
Vera P Krymskaya · University Of Pennsylvania · R01 · FY2018 · HL

Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas

$633,869
Duane A. Mitchell · University Of Florida · R01 · FY2017 · CA

Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas

$633,869
Duane A. Mitchell · University Of Florida · R01 · FY2018 · CA

Processed Antigen Characterization by Mass Spectrometry

$633,862
Donald F Hunt · University Of Virginia · R01 · FY2015 · AI

Three-dimensional conformation changes associated with T cell memory and autoimmunity

$633,827
Raymond David Hawkins · University Of Washington · U01 · FY2022 · DK

Targeting Tryptophan Metabolism in Rectal Cancer

$633,826
Matthew Aaron Ciorba · Washington University · R01 · FY2025 · CA

Cellular Therapy for Type 1 Diabetes using Mesenchymal Stem Cells

$633,812
Hongjun Wang · Medical University Of South Carolina · R01 · FY2025 · DK

Image-based models of tumor-immune dynamics in glioblastoma

$633,782
Kristin R Swanson · Mayo Clinic Arizona · U01 · FY2024 · CA

ELIMINATING EX VIVO MANIPULATION AND VIRAL TRANSFECTION OF T CELLS IN CAR T-CELL IMMUNOTHERAPY OF B-CELL MALIGNANCIES USING ULTRASOUND-BASED GENE DEL

$633,771
The University Of Texas Southwestern Medical Center · · FY2017 · Department of the Army

Administrative Core

$633,675
Haifa Shen · Methodist Hospital Research Institute · U54 · FY2019 · CA

Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy

$633,662
Taha Merghoub · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA

Improving IL12 Immunogene Therapy for Glioblastoma Based on Human Clinical Trial Results

$633,656
E. Antonio Chiocca · Brigham And Women'S Hospital · R01 · FY2024 · NS